home / press / releases

Menu
  • Search all tables

releases: https://guthrie.house.gov/news/documentsingle.aspx?DocumentID=391167

One row per release. Full-text search runs over title + body text.

Data license: MIT · Data source: dwillis/congress-press

This data as json

url title date year month party chamber state member_name bioguide_id domain scraper source date_source text has_text collected_at updated_at
https://guthrie.house.gov/news/documentsingle.aspx?DocumentID=391167 Guthrie Committee-Led Bills Pass House to Combat Manufacturing of Illicit Drugs and Protect Americans from Dangerous Substances 2026-09-16 2026 2026-09 Republican House KY Brett Guthrie G000558 guthrie.house.gov guthrie https://guthrie.house.gov/news scraper WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, issued the following statement following the House passage of three Committee-led bills to combat the manufacturing of illicit drugs and to protect Americans from dangerous substances, like fentanyl. “I am glad to see the House take action to pass three House Energy and Commerce bills to build upon our work of combating illicit drugs that have devastated communities across our nation, especially here in Kentucky,” said Congressman Guthrie. “These bipartisan bills will provide law enforcement additional tools to combat the production of fentanyl and other illicit drugs, protect Americans from dangerous substances, increase access to fentanyl testing, and most importantly save lives.” Background: H.R. 1266, Combating Illicit Xylazine Act – This legislation passed the House of Representatives unanimously. If enacted, this bill would place xylazine in Schedule III of the Controlled Substances Act and amend the definition of “ultimate user” to allow xylazine to continue to be lawfully administered for legitimate veterinary purposes. This bill requires a report to Congress on the prevalence and proliferation of xylazine trafficking and misuse in the United States. H.R. 8005, Stop Pills That Kill Act – This legislation passed the House of Representatives unanimously. If enacted, this bill would seek to prevent the misuse of pill press machines and their critical parts for the illicit manufacture of a controlled substance by strengthening the DEA’s ability to conduct regulatory oversight of pill press machines and their critical parts. H.R. 2004, Tyler’s Law – This legislation passed the House of Representatives unanimously. If enacted, this bill would direct the Secretary of Health and Human Services (HHS) to complete a study and issue guidance on whether hospital emergency departments should implement fentanyl testing as a routine procedure for patients experiencing an overdose. 1 2026-09-17T09:52:05Z 2026-09-17T09:53:00Z
Powered by Datasette · Queries took 0.842ms · Data license: MIT · Data source: dwillis/congress-press